Marc R. Schneebaum
|Age||Total Calculated Compensation||This person is connected to 15 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Mr. Marc R. Schneebaum has been Chief Financial Officer of Madrigal Pharmaceuticals, Inc. since July 22, 2016. Mr. Schneebaum has been Chief Financial Officer and Senior Vice President of Synta Pharmaceuticals Corp., since December 8, 2014 and serves its Treasurer. Mr. Schneebaum has over twenty years of demonstrated success in broad corporate finance, business development, technology development, sales & marketing and general management in life sciences (biotherapeutics, ...
128 Spring StreetPhone: 781-402-1780
Lexington, Massachusetts 02421
Board Members Memberships*
University of Maryland
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.